The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
CA19-9 - Wikipedia
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA 19-9 Antigen - an overview | ScienceDirect Topics
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Should I take a Cancer Marker Test? | Positive Bioscience
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
CA19-9 - Wikipedia
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - 2022 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net